Classification
GHK-Cu, KPV, TB-500, and BPC-157 research blend
Classification organizes the research catalogue. It is not a claim of safety, efficacy, or approved use.
For Research Use Only · Not For Human or Veterinary Use · UK Research Compounds

Four-analyte KLOW research blend containing GHK-Cu, KPV, TB-500, and BPC-157, with product-specific third-party documentation.
Four-analyte KLOW research blend containing GHK-Cu, KPV, TB-500, and BPC-157, with product-specific third-party documentation.
KLOW 80mg is a multi-analyte laboratory research material containing GHK-Cu, KPV, TB-500, and BPC-157. The product page and COA library identify the available analytical documentation for this exact blend. No human-use, dosing, administration, or therapeutic guidance is provided.
EVLV fulfills research products from the United States and publishes product-specific batch documentation when a matching laboratory report is available. Testing methods and results are specific to the product and batch identified in each report.
This product is supplied in the format shown on this page: lyophilized powder.
For laboratory research use only. Not for human or veterinary use.
Compound research context
The KLOW name describes the intended formulation. Verification depends on an exact report that identifies the blended sample and the analytical results available for each named component.
Open the complete KLOW Blend research hubClassification
Classification organizes the research catalogue. It is not a claim of safety, efficacy, or approved use.
Analytical review
Match the product name, total labeled quantity, sample or lot identifier, laboratory, and date. Read GHK-Cu, KPV, TB-500, and BPC-157 results separately instead of reducing the full blend to one headline number.
Available strengths
Product-specific questions
The KLOW research listing identifies GHK-Cu, KPV, TB-500, and BPC-157 as its four named components.
Match the exact sample, then evaluate the stated method and result for each named analyte.
No. A report for the blended sample does not replace documentation for a separately listed standalone product.
KLOW is a trade name used for a multi-analyte research blend, not a single peptide sequence. EVLV's KLOW 80mg research material identifies four components: GHK-Cu, KPV, TB-500, and BPC-157.
KLOW is not an FDA-approved drug. This material is not for human or veterinary use. EVLV does not provide dosing, administration, reconstitution, therapeutic, or body-function guidance.
KLOW is a trade name used for a multi-analyte research blend rather than a single peptide. EVLV's KLOW 80mg research material identifies GHK-Cu, KPV, TB-500, and BPC-157 as its four components.
The EVLV KLOW 80mg blend contains GHK-Cu, KPV, TB-500, and BPC-157. Exact-product analytical documentation should be reviewed to determine which identity, purity, and content results were reported for the current lot.
A multi-analyte blend should be evaluated against documentation that names the exact product and reports the methods and results for the identified components. A report for only one ingredient is not a substitute for an exact-product blend report.
No. KLOW is not an FDA-approved drug. EVLV supplies this product only as a laboratory research material, not for human or veterinary use, and provides no dosing, administration, or therapeutic guidance.